Goldline Pharmaceutical Ltd

BSE: 544759 · Pharmaceuticals & Biotechnology · 9 announcements

Share price

₹33.00

Market cap

₹31.68 Cr

Revenue (annual)

₹31.20 Cr

Net profit (annual)

₹4.12 Cr

P/E (TTM)

7.7×Sector 47.3×

Promoter holding

57.29%

FII holding

5.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.